COVID-19 WebinarsGlobal Health

COVID-19: The Invisible Impact on Team Members

By May 19, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.

Moderator

  • Brandon Thompson
    (Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)

Faculty

  • Richard G. Fried, MD, PhD
    (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
  •  John Connors
    (CEO & President, Jan Marini Skin Research)
  •  Mark Wilkins
    (Executive Vice President and U.S. General Manager, Prollenium Medical Technologies)
  •  Aaron Burton
    (CEO, Sciton)
  •  Jenna Mons Anderson
    (CEO, AccessElite)

You May Also Like

Journal of Drugs in Dermatology JDD Article about Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia AreataAlopeciaFeatured ArticlesLatest NewsEfficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 30, 2026

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

A practical review of efficacy, safety, and real world considerations for advanced practice providers This is a must-read JDD article on JAK inhibitors for alopecia areata. The review summarizes current…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?AestheticsAlopeciaFeatured ArticlesHairJDD Re:ViewLatest NewsJDD Re:View With Dr. Beer
March 26, 2026

JDD Re:View With Dr. Beer

Hair Disorders and Treatments   Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…
Featured ArticlesLatest NewsNailsProximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature
March 26, 2026

Proximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature

From the Vault: Pulled due to increased interest in rare onychomycosis presentations This case report dates back to JDD’s April 2018 issue. It’s a case report describing a healthy 51-year-old…

Leave a Reply